Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Health Priorities | 36 | 2023 | 382 | 7.570 |
Why?
|
Health Care Rationing | 31 | 2022 | 436 | 5.200 |
Why?
|
Health Policy | 23 | 2023 | 2698 | 2.430 |
Why?
|
Ethiopia | 27 | 2024 | 485 | 2.340 |
Why?
|
Quality-Adjusted Life Years | 20 | 2021 | 1737 | 2.280 |
Why?
|
Cost-Benefit Analysis | 39 | 2023 | 5526 | 1.960 |
Why?
|
Health Services | 8 | 2023 | 756 | 1.950 |
Why?
|
Delivery of Health Care | 23 | 2023 | 5370 | 1.940 |
Why?
|
Norway | 33 | 2022 | 499 | 1.810 |
Why?
|
Social Justice | 15 | 2021 | 485 | 1.660 |
Why?
|
Decision Making | 22 | 2022 | 3965 | 1.570 |
Why?
|
Health Expenditures | 13 | 2023 | 2387 | 1.500 |
Why?
|
Morals | 5 | 2021 | 288 | 1.470 |
Why?
|
Life Expectancy | 13 | 2024 | 1247 | 1.410 |
Why?
|
Health Services Accessibility | 23 | 2021 | 5508 | 1.310 |
Why?
|
Communicable Diseases | 6 | 2023 | 874 | 1.250 |
Why?
|
Child Mortality | 5 | 2024 | 204 | 1.200 |
Why?
|
Social Values | 9 | 2012 | 224 | 1.180 |
Why?
|
Health Facilities | 3 | 2023 | 577 | 1.170 |
Why?
|
Poverty | 18 | 2024 | 2714 | 1.160 |
Why?
|
Neglected Diseases | 2 | 2021 | 67 | 1.100 |
Why?
|
Health Status Disparities | 11 | 2023 | 1880 | 1.090 |
Why?
|
Maternal Mortality | 5 | 2015 | 313 | 1.050 |
Why?
|
Developing Countries | 14 | 2023 | 2911 | 1.040 |
Why?
|
Healthcare Disparities | 11 | 2021 | 3413 | 1.020 |
Why?
|
Health Care Reform | 5 | 2023 | 1259 | 0.980 |
Why?
|
Ethics, Medical | 9 | 2021 | 783 | 0.970 |
Why?
|
Health Planning | 3 | 2021 | 233 | 0.950 |
Why?
|
Physicians, Family | 4 | 2008 | 349 | 0.920 |
Why?
|
Policy Making | 6 | 2020 | 546 | 0.920 |
Why?
|
Resource Allocation | 12 | 2020 | 354 | 0.900 |
Why?
|
Nutrition Disorders | 2 | 2015 | 203 | 0.890 |
Why?
|
Technology Assessment, Biomedical | 4 | 2023 | 312 | 0.820 |
Why?
|
Tropical Medicine | 2 | 2021 | 52 | 0.810 |
Why?
|
Infant Mortality | 5 | 2017 | 751 | 0.790 |
Why?
|
Choice Behavior | 6 | 2018 | 844 | 0.780 |
Why?
|
Tanzania | 16 | 2017 | 1407 | 0.780 |
Why?
|
Patient Rights | 4 | 2018 | 126 | 0.770 |
Why?
|
Goals | 5 | 2018 | 719 | 0.760 |
Why?
|
Carbon Footprint | 1 | 2021 | 19 | 0.760 |
Why?
|
Models, Theoretical | 6 | 2022 | 3564 | 0.750 |
Why?
|
Public Health | 8 | 2022 | 2680 | 0.710 |
Why?
|
Communicable Disease Control | 3 | 2021 | 856 | 0.690 |
Why?
|
Immunity, Herd | 1 | 2020 | 48 | 0.680 |
Why?
|
Drug Costs | 3 | 2022 | 1193 | 0.680 |
Why?
|
Humans | 187 | 2024 | 765968 | 0.670 |
Why?
|
Contraceptive Agents | 1 | 2021 | 147 | 0.660 |
Why?
|
Euthanasia, Passive | 3 | 2010 | 64 | 0.660 |
Why?
|
Biodiversity | 1 | 2022 | 346 | 0.650 |
Why?
|
Carbon | 1 | 2023 | 677 | 0.650 |
Why?
|
Human Rights | 4 | 2018 | 312 | 0.650 |
Why?
|
Bicycling | 1 | 2020 | 176 | 0.640 |
Why?
|
Patient Selection | 8 | 2010 | 4255 | 0.640 |
Why?
|
Social Responsibility | 6 | 2023 | 382 | 0.630 |
Why?
|
Disabled Persons | 4 | 2017 | 1208 | 0.630 |
Why?
|
Financing, Government | 2 | 2021 | 473 | 0.620 |
Why?
|
Epidemics | 3 | 2021 | 514 | 0.600 |
Why?
|
Health Care Costs | 9 | 2023 | 3242 | 0.590 |
Why?
|
Health Status | 4 | 2020 | 4080 | 0.580 |
Why?
|
Contraception | 1 | 2021 | 361 | 0.570 |
Why?
|
Evidence-Based Medicine | 10 | 2017 | 3685 | 0.570 |
Why?
|
Insurance, Health | 6 | 2024 | 2521 | 0.570 |
Why?
|
Intensive Care Units, Neonatal | 3 | 2010 | 855 | 0.560 |
Why?
|
Life Support Care | 2 | 2010 | 226 | 0.550 |
Why?
|
Pandemics | 8 | 2021 | 8703 | 0.550 |
Why?
|
Cost of Illness | 5 | 2022 | 1950 | 0.520 |
Why?
|
Waiting Lists | 2 | 2016 | 777 | 0.520 |
Why?
|
Health Resources | 6 | 2019 | 949 | 0.510 |
Why?
|
Health Services Administration | 1 | 2016 | 63 | 0.500 |
Why?
|
Attitude of Health Personnel | 5 | 2008 | 3925 | 0.500 |
Why?
|
Ethical Analysis | 6 | 2018 | 41 | 0.490 |
Why?
|
Judicial Role | 1 | 2014 | 38 | 0.470 |
Why?
|
Preventive Medicine | 1 | 2016 | 246 | 0.470 |
Why?
|
Social Welfare | 2 | 2012 | 86 | 0.470 |
Why?
|
Prenatal Diagnosis | 1 | 2021 | 1268 | 0.460 |
Why?
|
Socioeconomic Factors | 17 | 2022 | 7838 | 0.450 |
Why?
|
World Health Organization | 7 | 2023 | 1328 | 0.440 |
Why?
|
Physician's Role | 5 | 2015 | 927 | 0.440 |
Why?
|
Preventive Health Services | 1 | 2018 | 570 | 0.430 |
Why?
|
Tropical Climate | 1 | 2013 | 35 | 0.430 |
Why?
|
Population Groups | 2 | 2018 | 209 | 0.430 |
Why?
|
Maternal Health Services | 4 | 2019 | 472 | 0.420 |
Why?
|
Maternal-Child Health Centers | 1 | 2012 | 41 | 0.410 |
Why?
|
Physicians | 5 | 2021 | 4588 | 0.410 |
Why?
|
Thiazides | 1 | 2012 | 19 | 0.410 |
Why?
|
Legislation, Drug | 1 | 2014 | 217 | 0.400 |
Why?
|
Practice Guidelines as Topic | 9 | 2018 | 7425 | 0.400 |
Why?
|
Catastrophic Illness | 2 | 2023 | 60 | 0.380 |
Why?
|
Ethics, Institutional | 1 | 2011 | 38 | 0.380 |
Why?
|
Sarcoma | 1 | 2022 | 1802 | 0.370 |
Why?
|
Medical Oncology | 1 | 2023 | 2339 | 0.360 |
Why?
|
Quality of Life | 7 | 2024 | 13462 | 0.360 |
Why?
|
General Practitioners | 1 | 2012 | 105 | 0.360 |
Why?
|
Ethics, Clinical | 1 | 2011 | 101 | 0.360 |
Why?
|
Injections, Intravenous | 1 | 2013 | 1377 | 0.360 |
Why?
|
Artemisinins | 3 | 2020 | 217 | 0.350 |
Why?
|
International Cooperation | 6 | 2021 | 1432 | 0.350 |
Why?
|
Medical Futility | 2 | 2009 | 136 | 0.350 |
Why?
|
Infant, Premature | 4 | 2010 | 2122 | 0.350 |
Why?
|
Randomized Controlled Trials as Topic | 7 | 2018 | 10383 | 0.340 |
Why?
|
Anti-Retroviral Agents | 2 | 2011 | 1787 | 0.340 |
Why?
|
National Health Programs | 2 | 2005 | 443 | 0.340 |
Why?
|
State Medicine | 3 | 2021 | 219 | 0.340 |
Why?
|
Health Status Indicators | 4 | 2014 | 966 | 0.340 |
Why?
|
Efficiency | 1 | 2013 | 480 | 0.340 |
Why?
|
Models, Econometric | 2 | 2009 | 213 | 0.330 |
Why?
|
Group Processes | 2 | 2008 | 224 | 0.330 |
Why?
|
Primary Prevention | 6 | 2016 | 1187 | 0.330 |
Why?
|
Staff Development | 1 | 2011 | 230 | 0.330 |
Why?
|
Antiretroviral Therapy, Highly Active | 3 | 2016 | 1899 | 0.320 |
Why?
|
Cross-Cultural Comparison | 2 | 2010 | 634 | 0.320 |
Why?
|
Models, Economic | 5 | 2020 | 716 | 0.320 |
Why?
|
Mortality | 6 | 2020 | 2904 | 0.320 |
Why?
|
Infant, Newborn | 19 | 2024 | 26346 | 0.320 |
Why?
|
Pediatrics | 2 | 2023 | 3606 | 0.310 |
Why?
|
Child Health Services | 3 | 2021 | 645 | 0.310 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3100 | 0.300 |
Why?
|
Alendronate | 2 | 2000 | 174 | 0.300 |
Why?
|
HIV Infections | 9 | 2016 | 17533 | 0.300 |
Why?
|
Substance Abuse, Intravenous | 1 | 2013 | 531 | 0.300 |
Why?
|
Antihypertensive Agents | 3 | 2012 | 2033 | 0.300 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3223 | 0.300 |
Why?
|
Reimbursement Mechanisms | 3 | 2017 | 672 | 0.300 |
Why?
|
Medical Staff, Hospital | 1 | 2012 | 601 | 0.300 |
Why?
|
Health Services Needs and Demand | 4 | 2018 | 1406 | 0.280 |
Why?
|
Infant, Low Birth Weight | 3 | 2021 | 871 | 0.280 |
Why?
|
Financial Support | 2 | 2018 | 116 | 0.280 |
Why?
|
Malaria | 5 | 2020 | 1246 | 0.280 |
Why?
|
Interviews as Topic | 10 | 2012 | 2739 | 0.280 |
Why?
|
Withholding Treatment | 3 | 2008 | 621 | 0.270 |
Why?
|
Child | 18 | 2024 | 80564 | 0.260 |
Why?
|
Program Development | 1 | 2012 | 1295 | 0.260 |
Why?
|
Health Promotion | 3 | 2017 | 2208 | 0.260 |
Why?
|
Neoplasms | 5 | 2023 | 22340 | 0.260 |
Why?
|
Female | 60 | 2024 | 396112 | 0.260 |
Why?
|
Financial Management | 1 | 2007 | 161 | 0.250 |
Why?
|
Patients | 2 | 2008 | 910 | 0.250 |
Why?
|
Climate Change | 2 | 2022 | 509 | 0.250 |
Why?
|
Family Practice | 1 | 2008 | 508 | 0.250 |
Why?
|
Vaccines | 1 | 2014 | 841 | 0.250 |
Why?
|
Parturition | 2 | 2021 | 454 | 0.250 |
Why?
|
Delivery, Obstetric | 3 | 2018 | 946 | 0.250 |
Why?
|
Income | 4 | 2021 | 1874 | 0.250 |
Why?
|
Cardiovascular Diseases | 6 | 2017 | 15652 | 0.250 |
Why?
|
Health Personnel | 3 | 2022 | 3390 | 0.250 |
Why?
|
Financing, Personal | 2 | 2019 | 310 | 0.240 |
Why?
|
Viral Vaccines | 2 | 2021 | 597 | 0.240 |
Why?
|
Philosophy, Medical | 1 | 2005 | 78 | 0.240 |
Why?
|
Role | 1 | 2005 | 176 | 0.240 |
Why?
|
Resuscitation Orders | 1 | 2007 | 275 | 0.230 |
Why?
|
Life Tables | 1 | 2024 | 363 | 0.230 |
Why?
|
Pregnancy | 16 | 2021 | 30260 | 0.230 |
Why?
|
Community Health Services | 2 | 2021 | 657 | 0.220 |
Why?
|
Specialization | 3 | 2015 | 777 | 0.220 |
Why?
|
Exercise | 1 | 2020 | 5937 | 0.220 |
Why?
|
Gatekeeping | 1 | 2003 | 49 | 0.220 |
Why?
|
Family Characteristics | 3 | 2023 | 1001 | 0.220 |
Why?
|
Patient Participation | 3 | 2008 | 1455 | 0.220 |
Why?
|
Infant, Premature, Diseases | 1 | 2009 | 713 | 0.210 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 5389 | 0.210 |
Why?
|
Pharmaceutical Preparations | 3 | 2017 | 1084 | 0.210 |
Why?
|
Adult | 32 | 2024 | 223044 | 0.210 |
Why?
|
Attitude to Death | 1 | 2006 | 399 | 0.210 |
Why?
|
Decision Support Techniques | 4 | 2018 | 2003 | 0.210 |
Why?
|
Rural Population | 6 | 2024 | 2317 | 0.200 |
Why?
|
Diagnostic Tests, Routine | 1 | 2008 | 790 | 0.200 |
Why?
|
Value of Life | 1 | 2003 | 97 | 0.200 |
Why?
|
Reoperation | 1 | 2013 | 4294 | 0.200 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2013 | 1566 | 0.200 |
Why?
|
Infant | 14 | 2024 | 36386 | 0.200 |
Why?
|
Program Evaluation | 1 | 2011 | 2499 | 0.200 |
Why?
|
United Nations | 2 | 2014 | 151 | 0.200 |
Why?
|
Child, Preschool | 13 | 2024 | 42500 | 0.200 |
Why?
|
Obstetric Labor Complications | 1 | 2004 | 240 | 0.200 |
Why?
|
Middle Aged | 30 | 2024 | 223009 | 0.190 |
Why?
|
Budgets | 1 | 2023 | 232 | 0.190 |
Why?
|
Obstetrics | 2 | 2007 | 680 | 0.190 |
Why?
|
Incidence | 7 | 2023 | 21480 | 0.190 |
Why?
|
Employment | 3 | 2019 | 1106 | 0.190 |
Why?
|
Antineoplastic Agents | 4 | 2022 | 13648 | 0.190 |
Why?
|
Costs and Cost Analysis | 4 | 2021 | 1668 | 0.190 |
Why?
|
Young Adult | 15 | 2024 | 59889 | 0.190 |
Why?
|
Decision Trees | 1 | 2023 | 509 | 0.180 |
Why?
|
Public Opinion | 2 | 2002 | 482 | 0.180 |
Why?
|
Male | 40 | 2024 | 363698 | 0.180 |
Why?
|
Adolescent | 15 | 2024 | 88835 | 0.180 |
Why?
|
Guideline Adherence | 3 | 2018 | 2243 | 0.170 |
Why?
|
Health Planning Guidelines | 1 | 2001 | 151 | 0.170 |
Why?
|
Urban Population | 3 | 2013 | 2040 | 0.170 |
Why?
|
Uganda | 7 | 2008 | 1353 | 0.170 |
Why?
|
Prenatal Care | 2 | 2018 | 1160 | 0.170 |
Why?
|
Delphi Technique | 1 | 2024 | 893 | 0.170 |
Why?
|
Medical Records Systems, Computerized | 1 | 2006 | 1195 | 0.170 |
Why?
|
India | 4 | 2017 | 2334 | 0.170 |
Why?
|
Age Factors | 7 | 2020 | 18380 | 0.170 |
Why?
|
Quinolines | 2 | 2016 | 769 | 0.160 |
Why?
|
Referral and Consultation | 3 | 2008 | 3615 | 0.160 |
Why?
|
Cost Sharing | 1 | 2023 | 409 | 0.160 |
Why?
|
Private Sector | 1 | 2023 | 396 | 0.160 |
Why?
|
Knowledge | 1 | 2001 | 178 | 0.160 |
Why?
|
Insecticide-Treated Bednets | 1 | 2020 | 70 | 0.160 |
Why?
|
Travel | 2 | 2021 | 806 | 0.160 |
Why?
|
Medicine | 2 | 2005 | 942 | 0.160 |
Why?
|
Quality of Health Care | 3 | 2018 | 4300 | 0.160 |
Why?
|
Physician-Patient Relations | 4 | 2008 | 3278 | 0.150 |
Why?
|
Costa Rica | 2 | 2018 | 186 | 0.150 |
Why?
|
Australia | 1 | 2022 | 1258 | 0.150 |
Why?
|
Altruism | 1 | 2020 | 211 | 0.150 |
Why?
|
Eligibility Determination | 1 | 2002 | 423 | 0.150 |
Why?
|
Hypertension | 4 | 2014 | 8626 | 0.150 |
Why?
|
HELLP Syndrome | 1 | 2018 | 41 | 0.150 |
Why?
|
Coronavirus | 1 | 2021 | 155 | 0.150 |
Why?
|
Antimalarials | 2 | 2016 | 913 | 0.150 |
Why?
|
Aged | 18 | 2024 | 171117 | 0.150 |
Why?
|
Malaria Vaccines | 1 | 2020 | 165 | 0.150 |
Why?
|
Fractures, Spontaneous | 1 | 2000 | 230 | 0.150 |
Why?
|
Terminal Care | 1 | 2010 | 1774 | 0.150 |
Why?
|
Family Planning Services | 1 | 2021 | 278 | 0.150 |
Why?
|
Cities | 1 | 2020 | 543 | 0.150 |
Why?
|
Insecticides | 1 | 2020 | 203 | 0.150 |
Why?
|
Gestational Age | 4 | 2018 | 3609 | 0.150 |
Why?
|
Eclampsia | 1 | 2018 | 61 | 0.140 |
Why?
|
Insurance Claim Review | 1 | 2002 | 746 | 0.140 |
Why?
|
Ethanolamines | 2 | 2016 | 152 | 0.140 |
Why?
|
Drugs, Essential | 1 | 2018 | 71 | 0.140 |
Why?
|
Lung Neoplasms | 1 | 2022 | 13451 | 0.140 |
Why?
|
Focus Groups | 4 | 2012 | 1459 | 0.140 |
Why?
|
Patients' Rooms | 1 | 2017 | 63 | 0.140 |
Why?
|
Drug Industry | 2 | 2021 | 791 | 0.140 |
Why?
|
Fluorenes | 2 | 2016 | 160 | 0.140 |
Why?
|
Osteoporosis, Postmenopausal | 1 | 2000 | 399 | 0.130 |
Why?
|
CD4 Lymphocyte Count | 2 | 2016 | 2587 | 0.130 |
Why?
|
Perinatal Mortality | 1 | 2017 | 103 | 0.130 |
Why?
|
Perinatal Care | 1 | 2019 | 246 | 0.130 |
Why?
|
Models, Statistical | 6 | 2018 | 5089 | 0.130 |
Why?
|
Disease | 1 | 2002 | 676 | 0.130 |
Why?
|
Statistics as Topic | 2 | 2014 | 2352 | 0.130 |
Why?
|
Health Surveys | 3 | 2016 | 4056 | 0.130 |
Why?
|
Anti-HIV Agents | 2 | 2011 | 4559 | 0.130 |
Why?
|
Diffusion of Innovation | 1 | 2001 | 721 | 0.130 |
Why?
|
Cross-Sectional Studies | 6 | 2022 | 26318 | 0.130 |
Why?
|
Professional Autonomy | 2 | 2008 | 172 | 0.130 |
Why?
|
Ethics | 1 | 1995 | 93 | 0.120 |
Why?
|
Health Transition | 1 | 2015 | 35 | 0.120 |
Why?
|
Temperature | 1 | 2022 | 2226 | 0.120 |
Why?
|
Forecasting | 1 | 2024 | 2936 | 0.120 |
Why?
|
Diphosphonates | 1 | 2000 | 625 | 0.120 |
Why?
|
Clinical Protocols | 2 | 2017 | 1441 | 0.120 |
Why?
|
Canada | 4 | 2015 | 2119 | 0.120 |
Why?
|
Emergency Medical Services | 2 | 2013 | 1938 | 0.120 |
Why?
|
Seroepidemiologic Studies | 1 | 2016 | 404 | 0.120 |
Why?
|
Severity of Illness Index | 3 | 2022 | 15880 | 0.120 |
Why?
|
Reproductive Health Services | 1 | 2015 | 90 | 0.110 |
Why?
|
Research Report | 1 | 2017 | 367 | 0.110 |
Why?
|
Prognosis | 7 | 2011 | 29922 | 0.110 |
Why?
|
Qualitative Research | 4 | 2011 | 3139 | 0.110 |
Why?
|
Rural Health | 2 | 2016 | 301 | 0.110 |
Why?
|
Trachoma | 1 | 2013 | 19 | 0.110 |
Why?
|
Insurance Coverage | 1 | 2005 | 1944 | 0.110 |
Why?
|
Hospital Departments | 1 | 1993 | 135 | 0.110 |
Why?
|
Elephantiasis, Filarial | 1 | 2013 | 31 | 0.110 |
Why?
|
Attitude to Health | 1 | 2002 | 2020 | 0.100 |
Why?
|
Onchocerciasis | 1 | 2013 | 28 | 0.100 |
Why?
|
Tuberculosis | 3 | 2014 | 2012 | 0.100 |
Why?
|
Personal Autonomy | 2 | 2005 | 315 | 0.100 |
Why?
|
Cost Control | 3 | 2003 | 624 | 0.100 |
Why?
|
Calcium Channel Blockers | 1 | 2016 | 686 | 0.100 |
Why?
|
Internationality | 3 | 2014 | 1007 | 0.100 |
Why?
|
Helminthiasis | 1 | 2013 | 81 | 0.100 |
Why?
|
Health Services Research | 3 | 2004 | 1808 | 0.100 |
Why?
|
Leukemia | 2 | 2008 | 1522 | 0.100 |
Why?
|
Anti-Infective Agents | 1 | 2020 | 986 | 0.100 |
Why?
|
Leishmaniasis, Visceral | 1 | 2013 | 99 | 0.100 |
Why?
|
Bone Marrow Transplantation | 1 | 2000 | 2729 | 0.100 |
Why?
|
Conservation of Natural Resources | 1 | 2014 | 209 | 0.100 |
Why?
|
Pregnancy Complications | 2 | 2013 | 2975 | 0.100 |
Why?
|
Emphysema | 1 | 2014 | 234 | 0.100 |
Why?
|
Birth Weight | 3 | 2022 | 2121 | 0.100 |
Why?
|
Mathematical Computing | 1 | 2011 | 143 | 0.100 |
Why?
|
Chronic Disease | 2 | 2017 | 9347 | 0.090 |
Why?
|
Policy | 1 | 2015 | 511 | 0.090 |
Why?
|
Reference Standards | 1 | 2015 | 1013 | 0.090 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2020 | 1560 | 0.090 |
Why?
|
Risk Factors | 10 | 2021 | 74840 | 0.090 |
Why?
|
Mothers | 1 | 2021 | 2210 | 0.090 |
Why?
|
Meta-Analysis as Topic | 1 | 2016 | 1370 | 0.090 |
Why?
|
Diabetic Angiopathies | 1 | 2016 | 805 | 0.090 |
Why?
|
Needs Assessment | 2 | 2015 | 1138 | 0.090 |
Why?
|
Accidents, Traffic | 1 | 2016 | 818 | 0.090 |
Why?
|
Checklist | 1 | 2018 | 848 | 0.090 |
Why?
|
Ambulatory Care | 1 | 2021 | 2778 | 0.090 |
Why?
|
Infant, Very Low Birth Weight | 2 | 2017 | 410 | 0.090 |
Why?
|
Dengue | 1 | 2013 | 257 | 0.080 |
Why?
|
Urban Health Services | 2 | 2016 | 176 | 0.080 |
Why?
|
Drugs, Generic | 2 | 2012 | 456 | 0.080 |
Why?
|
Bone Density | 2 | 2000 | 3491 | 0.080 |
Why?
|
Middle East | 2 | 2022 | 237 | 0.080 |
Why?
|
Diarrhea | 1 | 2016 | 1316 | 0.080 |
Why?
|
Chemoprevention | 1 | 2012 | 327 | 0.080 |
Why?
|
Risk Reduction Behavior | 1 | 2016 | 1123 | 0.080 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2016 | 1514 | 0.080 |
Why?
|
Research Design | 4 | 2017 | 6209 | 0.080 |
Why?
|
Judgment | 1 | 2011 | 270 | 0.080 |
Why?
|
Research | 1 | 1998 | 1975 | 0.080 |
Why?
|
Infant, Extremely Low Birth Weight | 1 | 2009 | 83 | 0.080 |
Why?
|
Pneumonia | 1 | 2021 | 2157 | 0.080 |
Why?
|
Endocarditis, Bacterial | 1 | 2013 | 434 | 0.080 |
Why?
|
Metabolic Diseases | 1 | 2015 | 687 | 0.080 |
Why?
|
Treatment Outcome | 10 | 2018 | 65188 | 0.080 |
Why?
|
Respiratory Tract Infections | 1 | 2016 | 1008 | 0.080 |
Why?
|
Ethics Committees | 1 | 2008 | 51 | 0.080 |
Why?
|
Efficiency, Organizational | 1 | 2013 | 697 | 0.080 |
Why?
|
Decision Support Systems, Clinical | 1 | 2018 | 1175 | 0.080 |
Why?
|
Child Welfare | 1 | 2012 | 521 | 0.070 |
Why?
|
Quality Indicators, Health Care | 1 | 2018 | 1806 | 0.070 |
Why?
|
Politics | 4 | 2005 | 822 | 0.070 |
Why?
|
Brain Damage, Chronic | 1 | 2008 | 265 | 0.070 |
Why?
|
Administrative Personnel | 1 | 2008 | 186 | 0.070 |
Why?
|
Dissent and Disputes | 1 | 2008 | 151 | 0.070 |
Why?
|
Occupational Diseases | 1 | 2015 | 1456 | 0.070 |
Why?
|
Pneumococcal Vaccines | 1 | 2011 | 414 | 0.070 |
Why?
|
Fractures, Bone | 1 | 1999 | 2041 | 0.070 |
Why?
|
Registries | 3 | 2018 | 8297 | 0.070 |
Why?
|
Evidence-Based Practice | 1 | 2011 | 500 | 0.070 |
Why?
|
Rural Health Services | 2 | 2016 | 393 | 0.070 |
Why?
|
Intensive Care Units | 2 | 2017 | 3800 | 0.070 |
Why?
|
Vaccination | 2 | 2021 | 3426 | 0.070 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 2007 | 247 | 0.070 |
Why?
|
Fertilization in Vitro | 1 | 1994 | 1306 | 0.070 |
Why?
|
Mexico | 1 | 2008 | 777 | 0.060 |
Why?
|
Trisomy | 1 | 2007 | 259 | 0.060 |
Why?
|
Life Style | 3 | 2008 | 3926 | 0.060 |
Why?
|
Aged, 80 and over | 4 | 2020 | 59489 | 0.060 |
Why?
|
Intensive Care, Neonatal | 1 | 2007 | 200 | 0.060 |
Why?
|
Bariatric Surgery | 1 | 2015 | 997 | 0.060 |
Why?
|
Epilepsy | 1 | 2020 | 3320 | 0.060 |
Why?
|
Patient Preference | 1 | 2012 | 952 | 0.060 |
Why?
|
Hospitals, Teaching | 1 | 2009 | 1158 | 0.060 |
Why?
|
Educational Status | 2 | 2012 | 2513 | 0.060 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2020 | 3646 | 0.060 |
Why?
|
Multiple Organ Failure | 1 | 2007 | 390 | 0.060 |
Why?
|
Aspirin | 1 | 2016 | 3134 | 0.060 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2016 | 2770 | 0.060 |
Why?
|
Obesity, Morbid | 1 | 2015 | 1292 | 0.060 |
Why?
|
Depressive Disorder, Major | 1 | 2021 | 4808 | 0.050 |
Why?
|
Liver Transplantation | 1 | 1996 | 2412 | 0.050 |
Why?
|
Trust | 1 | 2008 | 533 | 0.050 |
Why?
|
Risk Assessment | 4 | 2017 | 24282 | 0.050 |
Why?
|
Taxes | 1 | 2005 | 219 | 0.050 |
Why?
|
Aortic Valve | 1 | 2013 | 1968 | 0.050 |
Why?
|
Primary Health Care | 2 | 2016 | 4736 | 0.050 |
Why?
|
Drug Prescriptions | 1 | 2012 | 1662 | 0.050 |
Why?
|
Insurance Benefits | 1 | 2024 | 186 | 0.050 |
Why?
|
Africa, Northern | 1 | 2022 | 85 | 0.050 |
Why?
|
Decision Making, Organizational | 1 | 2003 | 136 | 0.050 |
Why?
|
Wounds and Injuries | 1 | 2015 | 2511 | 0.050 |
Why?
|
Quality Improvement | 1 | 2018 | 3853 | 0.050 |
Why?
|
Community Health Planning | 1 | 2003 | 164 | 0.050 |
Why?
|
Organizational Objectives | 2 | 2014 | 426 | 0.050 |
Why?
|
United States | 7 | 2020 | 72903 | 0.050 |
Why?
|
Time Factors | 4 | 2017 | 40065 | 0.050 |
Why?
|
Professional-Family Relations | 1 | 2006 | 501 | 0.050 |
Why?
|
Schizophrenia | 1 | 2020 | 6972 | 0.050 |
Why?
|
Heart Diseases | 1 | 2014 | 2821 | 0.050 |
Why?
|
Data Interpretation, Statistical | 1 | 2011 | 2686 | 0.050 |
Why?
|
Stroke | 2 | 2014 | 9747 | 0.050 |
Why?
|
Patient Advocacy | 2 | 2001 | 361 | 0.040 |
Why?
|
Government Programs | 1 | 2023 | 278 | 0.040 |
Why?
|
Environmental Exposure | 1 | 2015 | 4544 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2018 | 4873 | 0.040 |
Why?
|
Risk-Taking | 1 | 2005 | 1021 | 0.040 |
Why?
|
Transportation | 1 | 2021 | 217 | 0.040 |
Why?
|
Abnormalities, Multiple | 1 | 2007 | 1424 | 0.040 |
Why?
|
Prevalence | 1 | 2016 | 15842 | 0.040 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2007 | 1002 | 0.040 |
Why?
|
Drug Combinations | 2 | 2016 | 2077 | 0.040 |
Why?
|
Age Distribution | 2 | 2014 | 2858 | 0.040 |
Why?
|
Sex Factors | 2 | 2012 | 10603 | 0.040 |
Why?
|
Germany | 1 | 2000 | 882 | 0.040 |
Why?
|
Denmark | 1 | 2000 | 774 | 0.040 |
Why?
|
Ethical Theory | 1 | 2017 | 34 | 0.040 |
Why?
|
Hospitals, Public | 1 | 2019 | 203 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2021 | 12240 | 0.040 |
Why?
|
Online Systems | 1 | 2017 | 181 | 0.030 |
Why?
|
Patient Care Planning | 1 | 2002 | 906 | 0.030 |
Why?
|
Ethics, Research | 1 | 2017 | 178 | 0.030 |
Why?
|
Longevity | 1 | 2003 | 1087 | 0.030 |
Why?
|
Netherlands | 1 | 2000 | 2277 | 0.030 |
Why?
|
Pensions | 1 | 2015 | 16 | 0.030 |
Why?
|
House Calls | 1 | 2017 | 171 | 0.030 |
Why?
|
Sanitation | 1 | 2015 | 83 | 0.030 |
Why?
|
Culture | 1 | 2019 | 622 | 0.030 |
Why?
|
Smoking | 2 | 2017 | 9081 | 0.030 |
Why?
|
Workplace | 1 | 2021 | 873 | 0.030 |
Why?
|
Government | 1 | 1995 | 161 | 0.030 |
Why?
|
Empirical Research | 1 | 2014 | 119 | 0.030 |
Why?
|
Government Regulation | 2 | 1995 | 525 | 0.030 |
Why?
|
Financing, Organized | 1 | 1995 | 201 | 0.030 |
Why?
|
Consultants | 1 | 2014 | 57 | 0.030 |
Why?
|
Housing | 1 | 2019 | 683 | 0.030 |
Why?
|
Public Policy | 1 | 2018 | 551 | 0.030 |
Why?
|
Hospitals, District | 1 | 2014 | 115 | 0.030 |
Why?
|
Health Behavior | 2 | 2015 | 2650 | 0.030 |
Why?
|
Aging | 1 | 2012 | 8731 | 0.030 |
Why?
|
Urban Health | 1 | 2016 | 530 | 0.030 |
Why?
|
State Health Plans | 1 | 1994 | 220 | 0.020 |
Why?
|
Markov Chains | 1 | 2016 | 968 | 0.020 |
Why?
|
Genomics | 1 | 2008 | 5929 | 0.020 |
Why?
|
Expert Testimony | 1 | 2014 | 266 | 0.020 |
Why?
|
Parents | 1 | 2006 | 3592 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2009 | 9249 | 0.020 |
Why?
|
Critical Care | 1 | 2004 | 2712 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2000 | 4860 | 0.020 |
Why?
|
Head | 1 | 2017 | 925 | 0.020 |
Why?
|
Myocardial Infarction | 1 | 2012 | 11499 | 0.020 |
Why?
|
Body Height | 1 | 2017 | 1562 | 0.020 |
Why?
|
Emergency Treatment | 1 | 2013 | 494 | 0.020 |
Why?
|
Morbidity | 1 | 2015 | 1749 | 0.020 |
Why?
|
Sex Distribution | 1 | 2014 | 2263 | 0.020 |
Why?
|
Safety | 1 | 2014 | 1157 | 0.020 |
Why?
|
Perception | 1 | 2015 | 1205 | 0.020 |
Why?
|
Europe | 1 | 1996 | 3423 | 0.020 |
Why?
|
Breast Feeding | 1 | 2017 | 1364 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2015 | 2424 | 0.020 |
Why?
|
Africa South of the Sahara | 1 | 2011 | 751 | 0.020 |
Why?
|
Interprofessional Relations | 1 | 2014 | 999 | 0.020 |
Why?
|
Ovarian Neoplasms | 1 | 2005 | 4900 | 0.020 |
Why?
|
Consensus | 1 | 2017 | 3202 | 0.020 |
Why?
|
Colorectal Neoplasms | 1 | 2007 | 6942 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2014 | 2721 | 0.020 |
Why?
|
Nutritional Status | 1 | 2015 | 1620 | 0.020 |
Why?
|
Weight Gain | 1 | 2017 | 2355 | 0.020 |
Why?
|
Risk | 1 | 2019 | 9591 | 0.020 |
Why?
|
Social Class | 1 | 2015 | 2007 | 0.020 |
Why?
|
Internal Medicine | 1 | 1993 | 1064 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2008 | 18071 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2014 | 6203 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2000 | 12437 | 0.020 |
Why?
|
Residence Characteristics | 1 | 2016 | 2116 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 6309 | 0.020 |
Why?
|
Ontario | 1 | 2006 | 402 | 0.020 |
Why?
|
Child Development | 1 | 2017 | 2327 | 0.020 |
Why?
|
Occupational Exposure | 1 | 2015 | 1805 | 0.010 |
Why?
|
Cause of Death | 1 | 2014 | 3708 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2014 | 5302 | 0.010 |
Why?
|
Retrospective Studies | 3 | 2018 | 81514 | 0.010 |
Why?
|
Planning Techniques | 1 | 2003 | 81 | 0.010 |
Why?
|
Local Government | 1 | 2003 | 83 | 0.010 |
Why?
|
Anticholesteremic Agents | 1 | 2009 | 970 | 0.010 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2014 | 2187 | 0.010 |
Why?
|
Patient Acceptance of Health Care | 1 | 2016 | 3230 | 0.010 |
Why?
|
Databases, Factual | 1 | 2015 | 8067 | 0.010 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2005 | 1776 | 0.010 |
Why?
|
Survival Analysis | 1 | 2012 | 10070 | 0.010 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2005 | 3537 | 0.010 |
Why?
|
Blood Pressure | 1 | 2012 | 8532 | 0.010 |
Why?
|
Cohort Studies | 1 | 2018 | 41649 | 0.010 |
Why?
|
Oregon | 1 | 1994 | 148 | 0.010 |
Why?
|
Hospitals, Private | 1 | 1994 | 66 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2008 | 4058 | 0.010 |
Why?
|
Individuality | 1 | 1994 | 303 | 0.010 |
Why?
|
Prospective Studies | 1 | 2015 | 54802 | 0.010 |
Why?
|
Vulnerable Populations | 1 | 1994 | 718 | 0.000 |
Why?
|